GlaxoSmithKline (GSK) Presents: BENLYSTA (belimumab)
Posted over 3 years ago
This announcement has 2 attachments:
BENLYSTA (belimumab) is the first and only FDA -Approved Treatment for both Systemic Lupus Erythematosus (SLE) and Lupus Nephritis. Please see and share attached QR codes with patients and/or persons interested. Information is also available at benlysta.com